We report a case of diamniotic, dichorionic pregnancy that presented at 26 weeks with premature rupture of the first amniotic sac. Nine days later, premature labour and delivery of the first male twin took place, with death of the first twin. The second twin was left in utero. The management included combination of tocolytics, antibiotics and cervical cerclage. Caesarean section was performed 48 days later, at 34 weeks due to breech presentation and contractions. We delivered a live male infant with apgar scores 4/1 and 7/5 and 1680 gr weight. The infant was discharged home 29 days later.The implementation of assisted reproduction during the last ten years has increased the incidence of multiple pregnancies. In some cases one or more infants must be born due to intrauterine risks or stillbirth. According to the relevant literature there is an absence of unanimity on the best management for these pregnancies. The aim ofthis report is to add our experience to the currently limited literature.A 31 year-old nullipara woman was admitted to the hospital at the 26th week of a twin dichorionic, diamniotic pregnancy after in vitro fertilisation (IVF), because of premature rupture of the membranes of the first amniotic sac. The ultrasound examination revealed cephalic presentation of the first female fetus, whereas the second male fetus was breech. Both had normal amniotic fluid index and growth. Two independent placentas were also visualized.The patient was treated with bed rest, erythromycin 250 mg three times per day (TID) for 7 days, atociban iv for 48 hours and 24 mg betamethasone in two separate doses. Seven days later, the first infant was born, weighting 780 g, but died seven days later at the Neonatal Intensive Care Unit (NICU) because of severe lung prematurity. The contractions ceased after the delivery of the first fetus. A ligation of the umbilical cord was performed, as high in the cervix as possible, in aseptic conditions, and the placenta was left inside the uterus. A McDonald cervical cerclage was also performed. During the procedure a course ofiv coamoxyclav 1.2 gr was administered. In addition, prophylactic ritrodine iv was administered for 48 hours.The patient was kept in the hospital for close monitoring which involved daily auscultation of the fetal heart and measurement of body temperature, twice weekly full blood count, CRP and clotting screen and ultrasound examination for growth and doppler once weekly. Pregnancy was terminated by caesarean section 48 days later (34th week) due to uterine contractions and breech presentation. A male
The prenatal diagnosis of isolated unilateral reduction of the fetal upper limb is one of the most difficult problems. In our experience fetal extremities can be evaluated more easily in early pregnancy (between 12-14 weeks) by transvaginal sonography than later in pregnancy. P25.15Magnetic cell sorting and flow cytometry for the detection of fetal nucleated erythroblasts in maternal circulation during the first trimester of pregnancy We describe two methods for isolation of nucleated fetal red blood cells from peripheral maternal blood. We used magnetic cell sorting (MACS) and flow cytometry in order to isolate the fetal erythroblasts from 20 ml maternal peripheral blood. Method: In the first group of the study participated twenty pregnant women who were between 8 and 14 weeks of gestation (mean 10.8), and had low risk for Down syndrome according to their age (between 21 to 34 years old and mean 28.1). After removal of the mononuclear cell layer we have performed magnetic cell sorting twice by using the glycophorin A antibody and secondary antibody conjugated with magnetic beads. The positive cells have been held on the magnet and were maternal and fetal red cells. We have then added on the positive cells the monoclonal antibody for γ-chain and the fetal nucleated erythrocytes have been measured under light microscope. The second group in our study consisted of 15 pregnant women between 8 and 14 weeks of gestation and we performed flow cytometry. After removal of the mononuclear cell layer we have added the antibodies CD 45 ECD, CD 41 PE, GlycA PE and anti γ-FITC and performed flow cytometry. The isolated population of cells was CD45-, CD41-, GlycA+, IGγ+ and contains the nucleated red blood fetal cells. Results:The number of fetal erythrocytes we have counted with MACS was between 0 and 18, with mean number of 7.2, standard deviation (SD) 5.2 and standard error of mean (SEM) 1.17. We have managed to find these cells on the 18 out of 20 cases (90%). The mean number of the isolated cells with flow cytometry were 1138 (363-2560), SD 631.6 and SEM 163. The percentage of the isolated cells to the total cell population was 0.8% to 4.2% (mean 1.7%, SD 0.6) The aim of our study was to identify the nucleated red fetal blood cells in maternal blood. We have identified all the obstacles encountered in our experiments and we have finally managed to isolate few nucleated fetal red blood cells from the maternal circulation in most samples. P25.16What type of management should we choose with positive combined test and normal karyotype in the first trimester? D. Smetanova, E. Kulovany, B. Kubesova, M. Hynek Fetal Medicine, GENNET, Praha, Czech RepublicObjectives: To assess optimal pregnancy management in the case of first trimester combined test positivity and normal karyotype. Methods: Between 2004 and 2007 overall 9 524 first trimester combined tests were carried out and at 180 (1.8%). CVS was done due to combined risk of chromosomal aberration or presence of US fetal malformation. US scans were provided by FMF certified so...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.